Exodus Point Capital Management, LP Grifols Sa Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$15.15 - $19.78 $1.45 Million - $1.89 Million	-95,440 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$16.86 - $19.67 $1.61 Million - $1.88 Million	95,440 New	95,440 $1.76 Million
Q4 2019 Feb 14, 2020	SELL	$19.57 - $23.52 $1.51 Million - $1.82 Million	-77,205 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $1.3 Million - $1.49 Million	65,316 Added 549.38%	77,205 $1.55 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $209,127 - $250,857	11,889 New	11,889 $251,000

150

140M

3.54M

919K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.78B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.